Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $823.1150 (1.79%) ($823.1150 - $823.1150) on Thu. Nov. 30, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.06% (three month average) | RSI | 70 | Latest Price | $823.1150(1.79%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.6% a day on average for past five trading days. | Weekly Trend | REGN advances 0.7% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(52%) SDY(51%) SPLV(45%) XLV(44%) XLU(43%) | Factors Impacting REGN price | REGN will decline at least -0.53% in a week (0% probabilities). USO(-33%) ONLN(-30%) VXX(-28%) UNG(-26%) XLE(-22%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.53% (StdDev 1.06%) | Hourly BBV | 1.2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $805.61(2.17%) | 10 Day Moving Average | $802.89(2.52%) | 20 Day Moving Average | $805.97(2.13%) | To recent high | -2.7% | To recent low | 6.2% | Market Cap | $87.274b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |